fda semaglutide warning november 2025 Shares in Novo Nordisk, the Danish firm best known for its Wegovy and Ozempic weight loss drugs, have plunged after it called a halt to closely-watched trials on a treatment for Alzheimer's FDA warns Novo Nordisk over

Always reliable and easy Ordering from this site is always such a breeze

Reduced-calorie dietsa common outcome for those taking GLP-1s even if the goal isnt weight lossmay deplete these essential minerals

If you are breastfeeding or planning to become pregnant, discuss timing with your provider before switching

I explain a practical framework for designing a time-restricted eating window that aligns with your lifestyle, exercise schedule and social schedule

Clinical trials like STEP 1 established that 2.4mg weekly produces approximately 14.9% body weight reduction over 68 weeks

Its once-weekly dosing also provides convenience, making it a competitive option in the market